Aptiv price target lowered to $90 from $100 at Morgan Stanley

Morgan Stanley lowered the firm’s price target on Aptiv to $90 from $100 and keeps an Equal Weight rating on the shares. The firm said that Q3 U.S. supplier results were largely in-line but triggered some volatile stock reactions. While investors hit the exits on EV-exposed names, the firm sees value emerging in the ICE-exposed lineup.